BioPharmSignal logoBioPharmSignal

Biotech News

iSpecimen Appoints Eric Langlois as Chief Revenue Officer

iSpecimen (ISPC)iSpecimen2026-06-25 13:46 ESTCompany update

Mr. Langlois Led iSpecimen to 3,000 Percent Revenue Growth During His Tenure as the Company's Former SVP of Sales and Business Development

LEXINGTON, Mass., Jan. 24, 2023 (GLOBE NEWSWIRE) -- <a...

Open original release

Related news

ISPCiSpecimen2026-06-25 13:46 EST

iSpecimen to Participate in the ThinkEquity Conference on October 26, 2022

ISPCiSpecimen2026-06-25 13:46 EST

iSpecimen to Report Third Quarter 2022 Results on November 8, 2022

ISPCiSpecimen2026-06-25 13:46 EST

iSpecimen Launches New Open Feasibilities Dashboard on the iSpecimen Marketplace Platform to Enhance Biospecimen Fulfillment for Global Partner Network

ISPCiSpecimen2026-06-25 13:46 EST

iSpecimen Reports Third Quarter 2022 Financial and Operating Results

ISPCiSpecimen2026-06-25 13:46 EST

iSpecimen Appoints Joseph J. Basile to Board of Directors

ISPCiSpecimen2026-06-25 13:46 EST

iSpecimen Names Tracy Curley as Chief Executive Officer

ISPCiSpecimen2026-06-25 13:46 EST

iSpecimen to Participate in Maxim's Healthcare IT Virtual Conference on January 25, 2023

ISPCiSpecimen2026-06-25 13:46 EST

iSpecimen to Participate in the Sequire Biotechnology Conference on February 2, 2023

ISPCiSpecimen2026-06-25 13:46 EST

iSpecimen Expands Biospecimen Provider Network

ISPCiSpecimen2026-06-25 13:46 EST

iSpecimen to Report Fourth Quarter and Full Year 2022 Results on March 14, 2023

View all latest news

iSpecimen

iSpecimen is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

ISPCiSpecimen2026-06-26 10:40 EST

iSpecimen to Participate in the ThinkEquity Conference on October 26, 2022

ISPCiSpecimen2026-06-26 10:40 EST

iSpecimen to Report Third Quarter 2022 Results on November 8, 2022

ISPCiSpecimen2026-06-26 10:40 EST

iSpecimen Launches New Open Feasibilities Dashboard on the iSpecimen Marketplace Platform to Enhance Biospecimen Fulfillment for Global Partner Network

ISPCiSpecimen2026-06-26 10:40 EST

iSpecimen Reports Third Quarter 2022 Financial and Operating Results

ISPCiSpecimen2026-06-26 10:40 EST

iSpecimen Appoints Joseph J. Basile to Board of Directors

Stock data

Close
—
Market cap
—
Exchange
NASDAQ
Sector
Biotechnology
Location
United States